| Literature DB >> 35112321 |
Maria Rayane Correia de Oliveira1,2, Maria Gabriely de Lima Silva2, Antonia Thassya Lucas Dos Santos3, Francisco Lucas Alves Batista2, Roger Henrique Sousa da Costa2, Anita Oliveira Brito Pereira Bezerra Martins2, Beatriz Gonçalves da Cruz4, Maria Flaviana Bezerra Morais-Braga3, Henrique Douglas Melo Coutinho5, Francisco Ernani Alves Magalhães6, Diniz Maciel de Sena Junior4, Alexandre Magno Rodrigues Teixeira4, Irwin Rose Alencar de Menezes7.
Abstract
Due to the increase in fungal resistance to existing drugs, a need exists to search for new antifungals. This study aimed to evaluate the antifungal activity of α, β, and δ-damascone and inclusion complexes with β-cyclodextrin against different Candida spp. The inclusion complex of β-damascone was prepared by the co-evaporation method using three molar proportions (1:1; 2:1; 3:1 (βDA-βCD)) and analyzed using Fourier transform infrared spectroscopy (FTIR). Standard Candida albicans (CA INCQS 40,006), Candida krusei (CK INCQS 40,095), and Candida tropicalis (CT INCQS 40,042) strains were used to evaluate antifungal activity. The substances were tested individually or in association with fluconazole (FCZ). The IC50 and cell viability curve constructions were performed using the microdilution method. The minimum fungicidal concentration (MFC) was determined by the subculture method in a solid medium. The α, β, and δ-DA isolated or in combination with fluconazole (FCZ) showed significant antifungal activity. β-damascone showed effective complexation in the three molar proportions assayed; however, none of the inclusion complexes was demonstrated clinically significant effects against the fungal tested. Then, all compounds have shown promising antifungal activities; however, in vivo assays are necessary to have therapeutical application in the future.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35112321 DOI: 10.1007/s12223-021-00945-2
Source DB: PubMed Journal: Folia Microbiol (Praha) ISSN: 0015-5632 Impact factor: 2.099